A reduced binding capability of HSA for Co2+ was seen in 96% patients with myocardial ischemia.12 An albumin-cobalt-binding (ACB) assay, the only available method for detecting the plasma biomarker ischemia-modified albumin (IMA), was developed to rapidly diagnose this condition. This evidence concerns the gene ALB and ischemia.